Found: 150
Select item for more details and to access through your institution.
Interstitial Lung Disease: A Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2024, v. 332, n. 19, p. 1655, doi. 10.1001/jama.2024.3669
- By:
- Publication type:
- Article
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an AJRCCM Special Issue.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1049, doi. 10.1164/rccm.202404-0675ED
- By:
- Publication type:
- Article
Gazing into the Proteomic Crystal Ball: Predicting Survival in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1056, doi. 10.1164/rccm.202311-2108ED
- By:
- Publication type:
- Article
A Long and Winding Road: Drug Development in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1072, doi. 10.1164/rccm.202402-0290VP
- By:
- Publication type:
- Article
Cough Severity Visual Analog Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 9, p. 1165, doi. 10.1164/rccm.202311-2169LE
- By:
- Publication type:
- Article
[<sup>18</sup>F]FDG PET/CT Signal Correlates with Neoangiogenesis Markers in Patients with Fibrotic Interstitial Lung Disease Who Underwent Lung Biopsy: Implication for the Use of PET/CT in Diffuse Lung Diseases.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 617, doi. 10.2967/jnumed.123.266445
- By:
- Publication type:
- Article
Estimating the effect of nintedanib on forced vital capacity in children and adolescents with fibrosing interstitial lung disease using a Bayesian dynamic borrowing approach.
- Published in:
- Pediatric Pulmonology, 2024, v. 59, n. 4, p. 1038, doi. 10.1002/ppul.26882
- By:
- Publication type:
- Article
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 6, p. 647, doi. 10.1164/rccm.202312-2213SO
- By:
- Publication type:
- Article
Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 4, p. 362, doi. 10.1164/rccm.202307-1154WS
- By:
- Publication type:
- Article
Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT.
- Published in:
- Efficacy & Mechanism Evaluation (EME), 2024, v. 11, n. 4, p. vii, doi. 10.3310/LYWQ8541
- By:
- Publication type:
- Article
Challenges and Opportunities for Commercializing Technologies in the Pulmonary Arena: An Official American Thoracic Society Report.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 1, p. 1, doi. 10.1513/AnnalsATS.202310-872ST
- By:
- Publication type:
- Article
An adjudication algorithm for respiratory-related hospitalisation in idiopathic pulmonary fibrosis.
- Published in:
- ERJ Open Research, 2024, v. 10, n. 1, p. 1, doi. 10.1183/23120541.00636-2023
- By:
- Publication type:
- Article
Decline in forced vital capacity as a surrogate for mortality in patients with pulmonary fibrosis.
- Published in:
- Respirology, 2023, v. 28, n. 12, p. 1147, doi. 10.1111/resp.14579
- By:
- Publication type:
- Article
Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2023, v. 208, n. 9, p. 975, doi. 10.1164/rccm.202305-0796OC
- By:
- Publication type:
- Article
Lung extracellular matrix modulates KRT5<sup>+</sup> basal cell activity in pulmonary fibrosis.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41621-y
- By:
- Publication type:
- Article
Ziritaxestat and Lung Function in Idiopathic Pulmonary Fibrosis—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 10, p. 973, doi. 10.1001/jama.2023.12640
- By:
- Publication type:
- Article
The Burden and Impact of Cough in Patients with Idiopathic Pulmonary Fibrosis: An Analysis of the Prospective Observational PROFILE Study.
- Published in:
- Annals of the American Thoracic Society, 2023, v. 20, n. 9, p. 1267, doi. 10.1513/AnnalsATS.202302-174OC
- By:
- Publication type:
- Article
Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis.
- Published in:
- ERJ Open Research, 2023, v. 9, n. 4, p. 1, doi. 10.1183/23120541.00690-2022
- By:
- Publication type:
- Article
Change in gait speed and adverse outcomes in patients with idiopathic pulmonary fibrosis: A prospective cohort study.
- Published in:
- Respirology, 2023, v. 28, n. 7, p. 649, doi. 10.1111/resp.14494
- By:
- Publication type:
- Article
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 18, p. 1567, doi. 10.1001/jama.2023.5355
- By:
- Publication type:
- Article
MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
- Published in:
- Respirology, 2023, v. 28, n. 5, p. 455, doi. 10.1111/resp.14440
- By:
- Publication type:
- Article
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1870, doi. 10.1093/rheumatology/keac535
- By:
- Publication type:
- Article
Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial.
- Published in:
- Respiratory Research, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s12931-023-02371-z
- By:
- Publication type:
- Article
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.
- Published in:
- European Respiratory Review, 2023, v. 32, n. 167, p. 1, doi. 10.1183/16000617.0206-2022
- By:
- Publication type:
- Article
Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease.
- Published in:
- Rheumatology, 2023, v. 62, p. SI43, doi. 10.1093/rheumatology/keac325
- By:
- Publication type:
- Article
Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.
- Published in:
- Clinical Reviews in Allergy & Immunology, 2022, v. 63, n. 3, p. 472, doi. 10.1007/s12016-022-08926-0
- By:
- Publication type:
- Article
Tackling the Neuropathic Cough of Idiopathic Pulmonary Fibrosis (IPF): More Needs to be Done.
- Published in:
- Lung, 2022, v. 200, n. 6, p. 673, doi. 10.1007/s00408-022-00589-0
- By:
- Publication type:
- Article
A review of the challenges, learnings and future directions of home handheld spirometry in interstitial lung disease.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02221-4
- By:
- Publication type:
- Article
Effect of Nintedanib on Progression of Systemic Sclerosis‐Associated Interstitial Lung Disease Over 100 Weeks: Data From a Randomized Controlled Trial.
- Published in:
- ACR Open Rheumatology, 2022, v. 4, n. 10, p. 837, doi. 10.1002/acr2.11483
- By:
- Publication type:
- Article
Genome-wide Enrichment of TERT Rare Variants in Idiopathic Pulmonary Fibrosis Patients of Latino Ancestry.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 7, p. 903, doi. 10.1164/rccm.202203-0622LE
- By:
- Publication type:
- Article
Reply to Fujimoto : The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice.
- Published in:
- 2022
- By:
- Publication type:
- letter
Biomarkers for Interstitial Lung Abnormalities: A Stepping-stone Toward Idiopathic Pulmonary Fibrosis Prevention?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Meta-Analysis of Effect of Nintedanib on Reducing FVC Decline Across Interstitial Lung Diseases.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 7, p. 3392, doi. 10.1007/s12325-022-02145-x
- By:
- Publication type:
- Article
Rare and Common Variants in Contribute to Genetic Risk of Idiopathic Pulmonary Fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 206, n. 1, p. 56, doi. 10.1164/rccm.202110-2439OC
- By:
- Publication type:
- Article
CYFRA 21-1 Predicts Progression in Idiopathic Pulmonary Fibrosis: A Prospective Longitudinal Analysis of the PROFILE Cohort.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 9, p. 1084, doi. 10.1164/rccm.202106-1485OC
- By:
- Publication type:
- Article
: Do Monocytes Predict the Fate of Interstitial Lung Abnormalities?
- Published in:
- 2022
- By:
- Publication type:
- editorial
PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Candidate role for Toll-like receptor 3 L412F polymorphism and infection in acute exacerbation of idiopathic pulmonary fibrosis.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2022, v. 205, n. 5, p. E1, doi. 10.1164/rccm.202010-3880oc
- By:
- Publication type:
- Article
Candidate Role for Toll-like Receptor 3 L412F Polymorphism and Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical Utility of Home versus Hospital Spirometry in Fibrotic Interstitial Lung Disease: Evaluation after INJUSTIS Interim Analysis.
- Published in:
- 2022
- By:
- Publication type:
- letter
Short‐term lung function changes predict mortality in patients with fibrotic hypersensitivity pneumonitis.
- Published in:
- Respirology, 2022, v. 27, n. 3, p. 202, doi. 10.1111/resp.14204
- By:
- Publication type:
- Article
Using Data on Survival with Idiopathic Pulmonary Fibrosis to Estimate Survival with Other Types of Progressive Fibrosis Interstitial Lung Disease: A Bayesian Framework.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 2, p. 1045, doi. 10.1007/s12325-021-02014-z
- By:
- Publication type:
- Article
Pirfenidone in Unclassifiable Interstitial Lung Disease: A Subgroup Analysis by Concomitant Mycophenolate Mofetil and/or Previous Corticosteroid Use.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 2, p. 1081, doi. 10.1007/s12325-021-02009-w
- By:
- Publication type:
- Article
Reply.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Small Airways in Idiopathic Pulmonary Fibrosis: Quiet but Not Forgotten.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2021, v. 204, n. 9, p. 1010, doi. 10.1164/rccm.202108-2007ED
- By:
- Publication type:
- Article
DNA Methylome Alterations are Associated with Airway Macrophage Differentiation and Phenotype During Lung Fibros.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2021, v. 204, n. 8, p. E1, doi. 10.1164/rccm.202101-0004oc
- By:
- Publication type:
- Article
DNA Methylome Alterations Are Associated with Airway Macrophage Differentiation and Phenotype during Lung Fibrosis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Targeting Human Herpesviruses: An Effective Strategy for Treating Idiopathic Pulmonary Fibrosis?
- Published in:
- 2021
- By:
- Publication type:
- editorial